Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.495 CAD | +3.12% | +3.12% | +15.12% |
Mar. 27 | Satellos Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 27 | Satellos Bioscience Announces FY 2023 Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.12% | 39.55M | |
-2.43% | 103B | |
+1.35% | 95.28B | |
+1.51% | 22.15B | |
-15.56% | 21.02B | |
-8.38% | 18.15B | |
-41.01% | 16.73B | |
-13.43% | 16.05B | |
+4.07% | 13.68B | |
+34.72% | 12.17B |
- Stock Market
- Equities
- MSCL Stock
- News Satellos Bioscience Inc.
- Satellos Bioscience Inc. Brief: Announced Earlier Tuesday Management Team Update; Alan K. Jacobs, Chief Medical Officer Has Left to Pursue Other Opportunities; Jordan Dubow Engaged As Chief Medical Advisor